| 中文名称 | 帕苯咪唑 |
|---|---|
| 中文别名 | 帕苯咪唑;虫帕唑;5-丁基-2-苯并咪唑氨基甲酸甲酯;丁苯咪唑;帕苯达唑;帕苯达唑 USP标准品;(5-丁基-1H-苯并咪唑-2-基)氨基甲酸甲酯;5(6)-丁基-2-苯并咪唑氨基甲酸甲酯;丁苯咪酯;丁苯咪胺酯;帕苯咪唑溶液,100PPM |
| 英文名称 | Parbendazole |
| 英文别名 | Methyl (5-butyl-1H-benzo[d]imidazol-2-yl)carbamate;5-Butyl-2-benzimidazolecarbamic acid methyl ester;5-Butyl-2-(carbomethoxyamino)benzimidazole;Parbendazole;Parbendazole-D3;5-butyl-2-benzimidazolecarbamicacimethylester;helmatac;Methyl (5-butyl-1H-benzoimidazol-2-yl)carbamate;methyl5-butyl-2-benzimidazolecarbamate;pbdz;verminum;skf29044;Parbendazole (200 mg);Parbendazole Solution, 100ppm;Worm Guard;Helatac;SKF 29044;Parbendazol [INN-Spanish];Parbendazolum [INN-Latin];METHYL 5-BUTYL-2-BENZIMIDAZOLECARBAMATE;SK&F 29044;Carbamic acid, (5-butyl-1H-benzimidazol-2-yl)-, methyl ester;N4X8WVX2UG;methyl N-(6-butyl-1H-benzimidazol-2-yl)carbam;HY-115364;AB00514054;AMY13606;CHEMBL528271;AS-68370;Prestwick3_001110;SR-01000872691-1;NCGC00016706-01;PARBENDAZOLE [INN];14255-87-9;WLN: T56 BM DNJ CMVO1 G4;AKOS015898352;14255-87-9 (free base);Prestwick2_001110;methyl N-(5-butyl-1H-benzimidazol-2-yl)carbamate;PARBENDAZOLE [MI];methyl 5-butyl-1H-benzimidazol-2-ylcarbamate;SCHEMBL259455;4-(tert-Butoxycarbonyl)thiomorpholine-3-carboxylicacid;BRD-K02407574-001-03-0;Methyl (5-butyl-1H-benzimidazol-2-yl)carbamate;NCGC00016706-02;Prestwick0_001110;Parbendazole (USAN/INN);Parbendazole, United States Pharmacopeia (USP) Reference Standard;BPBio1_001342;Parbendazol;Methyl 5-butylbenzimidazole-2-carbamate;NCGC00016706-03;HMS1571M22;Parbendazolum;UNII-N4X8WVX2UG;Tox21_110571;Methyl (6-butyl-1H-benzo[d]imidazol-2-yl)carbamate;s2444;BRD-K02407574-001-04-8;SKF-29044;AC-1936;Methyl 5(6)-butyl-2-benzimidazolecarbamate;HMS2098M22;BRD-K02407574-001-06-3;NCGC00016706-04;CS-0035171;CAS-14255-87-9;AKOS015967508;D05365;SK&F-29044;(4-Butyl-1H-benzimidazol-2-yl)-carbamic acid methyl ester;TCMDC-131798;Prestwick1_001110;MFCD00864534;DTXCID8025410;N-(6-Butyl-1H-benzimidazol-2-yl)carbamic Acid Methyl Ester;BSPBio_001220;CHEBI:94267;PARBENDAZOLE [USAN];HMS3715M22;CCG-221110;Parbendazole free base;2-carbomethoxyamino-5-n-butylbenzimidazole;2H-Benzimidazole, carbamic acid deriv.;CARBAMIC ACID, N-(6-BUTYL-1H-BENZIMIDAZOL-2-YL)-, METHYL ESTER;FT-0630413;Q27166068;NSC 256420;Tox21_110571_1;NSC-256420;F18423;(5-Butyl-2-benzimidazole)carbamic acid methyl ester;N-(Butyl-5, benzimidazolyl)-2, carbamate de methyle [French];NCGC00016706-05;DTXSID0045410;methyl N-(6-butyl-1H-benzimidazol-2-yl)carbamate;Parbendazole [USAN:INN:BAN];PARBENDAZOLE [USP-RS];NCGC00016706-07;SR-01000872691;methyl ~{N}-(5-butyl-1~{H}-benzimidazol-2-yl)carbamate;2-Benzimidazolecarbamic acid, 5-butyl-, methyl ester;Methyl 5-butyl-1H-benzo[d]imidazol-2-ylcarbamate;Parbendazole, VETRANAL(TM), analytical standard;NSC256420;SPBio_003090;H1C;NS00024636;A885179;N-(Butyl-5, benzimidazolyl)-2, carbamate de methyle;EINECS 238-133-3;METHYL N-(5-BUTYL-1H-1,3-BENZODIAZOL-2-YL)CARBAMATE;Parbendazole?;YRWLZFXJFBZBEY-UHFFFAOYSA-N;BRD-K02407574-001-09-7 |
| CAS No. | 14255-87-9 |
| 分子式 | C13H17N3O2 |
| 分子量 | 247.29 |
4-(2-((2R,3R)-3-(2,5-二氟苯基)-3-羟基-4-(1H-1,2,4-三唑-1-基)丁-2-基)噻唑-4-基)苯甲腈
N-(丁基磺酰基)-O-[4-(4-哌啶基)丁基]-L-酪氨酸盐酸盐一水合物
2-(4-(1-羟基-4-(4-(羟基二苯基甲基)哌啶-1-基)丁基)苯基)-2-甲基丙酸
7-环戊基-N,N-二甲基-2-((5-(哌嗪-1-基)吡啶-2-基)氨基)-7H-吡咯并[2,3-d]嘧啶-6-甲酰胺
(1-((2R,3R,4S,5R)-3,4-二羟基-5-甲基四氢呋喃-2-基)-5-氟-2-氧代-1,2-二氢嘧啶-4-基)氨基甲酸戊酯
((3S,5R)-5-((1H-1,2,4-三唑-1-基)甲基)-5-(2,4-二氟苯基)四氢呋喃-3-基)甲基 4-甲基苯磺酸酯
N-(3-氯-4-氟苯基)-7-甲氧基-6-(3-吗啉-4-丙氧基)喹唑啉-4-胺
(6R,7R)-3-甲基-7-[(R)-2-氨基-2-苯乙酰氨基]-8-氧-5-硫杂-1-双环[4.2.0]辛-2-烯-2-甲酸
(2R,3S,5S)-3-苄氧基-5-[2-[[(4-甲氧基苯基)二苯基甲基]氨基]-6-苄氧基-9H-嘌呤-9-基]-2-苄氧基甲基环戊醇
(2R,3R,4S,5R)-2-(4-氨基吡咯并[2,1-F][1,2,4]三嗪-7-基)-3,4-二羟基-5-(羟甲基)四氢呋喃-2-甲腈
本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。
CopyRight @2025 广东元丰化学试剂有限公司 版权所有 | 隐私政策 条款及条件 | 粤ICP备2025403430号-1
技术支持:库价化学